FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200001593> ?p ?o ?g. }

• W4200001593 endingPage "S753" @default.
• W4200001593 startingPage "S752" @default.
• W4200001593 abstract "Abstract Background The burden of Respiratory Syncytial Virus (RSV)-associated hospitalization in adults is incompletely understood. The COVID-19 pandemic has resulted in multiple public health measures (e.g., social distancing, handwashing, masking) to decrease SARS-CoV-2 transmission, which could impact RSV-associated hospitalizations. We sought to compare RSV-associated hospitalizations from 2 pre- and one mid-COVID-19 winter viral respiratory seasons. Methods We conducted an IRB-approved prospective surveillance at two Atlanta-area hospitals during the winter respiratory viral seasons from Oct 2018–Apr 2021 for adults ≥ 50 years of age admitted with acute respiratory infections (ARI) and adults of any age with COPD or CHF-related admissions. Adults were eligible if they were residents of an 8 county region surrounding Atlanta, Georgia. Those with symptoms &gt; 14 days were excluded. Standard of care test results were included. Asymptomatic adults ≥ 50 years of age were enrolled as controls in Seasons 1 and 2. Nasopharyngeal swabs from cases and controls were tested for RSV using BioFire® FilmArray® Respiratory Viral Panel (RVP). We compared the demographic features and outcomes of RSV+ cases and controls. Results RSV was detected in 71/2,728 (2.6%) hospitalized adults with ARI, CHF, or COPD and 4/466 (0.9%) controls. In Season 1, RSV occurred in 5.9% (35/596 patients), in Season 2 3.6% (35/970 patients), but in only 0.09% (1/1,162 patients) in Season 3 (P &lt; 0.001 for both seasons). RSV detection in Season 3 was similar to RSV detection among controls during Seasons 1 and 2 (P=0.6). Median age of cases and controls was 67 years (Table 1). Of cases with RSV 11% were admitted to the ICU and two required mechanical ventilation. The majority of hospitalized patients were discharged home (95.8%) with a median length of hospitalization of three days (IQR 2-7). Table 1. Demographic Features and Outcomes Among RSV-Positive Hospitalized Adults. Conclusion Over 3 seasons, RSV was detected in 2.6% of adults admitted to the hospital with ARI, CHF or COPD. The rate of RSV dramatically declined during the 2020-21 winter respiratory viral season, likely due to public health measures implemented in response to COVID-19. Disclosures David L. Swerdlow, MD, Pfizer Vaccines (Employee) Robin Hubler, MS, Pfizer Inc. (Employee) Larry Anderson, MD, ADVI (Consultant)Bavarian Nordic (Consultant)Novavax (Consultant)Phizer (Grant/Research Support, Scientific Research Study Investigator)Sciogen (Research Grant or Support) Christina A. Rostad, MD, BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Moderna, Novavax, PaxVax, Pfizer, Regeneron, Sanofi-Pasteur. (Grant/Research Support, Scientific Research Study Investigator, Research Grant or Support)Meissa Vaccines (Other Financial or Material Support, Co-inventor of patented RSV vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc.) Nadine Rouphael, MD, pfizer, sanofi, lily, quidel, merck (Grant/Research Support) Nadine Rouphael, MD, Lilly (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Merck (Individual(s) Involved: Self): Emory study PI, Grant/Research Support; Pfizer: I conduct as co-PI the RSV PFIZER study at Emory, Research Grant; Pfizer (Individual(s) Involved: Self): Grant/Research Support, I conduct as co-PI the RSV PFIZER study at Emory; Quidel (Individual(s) Involved: Self): Emory Study PI, Grant/Research Support; Sanofi Pasteur (Individual(s) Involved: Self): Chair phase 3 COVID vaccine, Grant/Research Support Evan J. Anderson, MD, GSK (Scientific Research Study Investigator)Janssen (Consultant, Scientific Research Study Investigator, Advisor or Review Panel member)Kentucky Bioprocessing, Inc (Advisor or Review Panel member)MedImmune (Scientific Research Study Investigator)Medscape (Consultant)Merck (Scientific Research Study Investigator)Micron (Scientific Research Study Investigator)PaxVax (Scientific Research Study Investigator)Pfizer (Consultant, Grant/Research Support, Scientific Research Study Investigator)Regeneron (Scientific Research Study Investigator)Sanofi Pasteur (Consultant, Scientific Research Study Investigator)" @default.
• W4200001593 created "2021-12-31" @default.
• W4200001593 creator A5008929561 @default.
• W4200001593 creator A5015485949 @default.
• W4200001593 creator A5017852065 @default.
• W4200001593 creator A5026664731 @default.
• W4200001593 creator A5040670236 @default.
• W4200001593 creator A5041183761 @default.
• W4200001593 creator A5046895922 @default.
• W4200001593 creator A5050186673 @default.
• W4200001593 creator A5052029724 @default.
• W4200001593 creator A5053600656 @default.
• W4200001593 creator A5057537741 @default.
• W4200001593 creator A5058017922 @default.
• W4200001593 creator A5065877091 @default.
• W4200001593 creator A5074893397 @default.
• W4200001593 creator A5075978935 @default.
• W4200001593 creator A5077183317 @default.
• W4200001593 creator A5077266079 @default.
• W4200001593 creator A5079489250 @default.
• W4200001593 creator A5081122395 @default.
• W4200001593 creator A5083052414 @default.
• W4200001593 creator A5089637129 @default.
• W4200001593 date "2021-11-01" @default.
• W4200001593 modified "2023-09-26" @default.
• W4200001593 title "1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)" @default.
• W4200001593 doi "https://doi.org/10.1093/ofid/ofab466.1521" @default.
• W4200001593 hasPublicationYear "2021" @default.
• W4200001593 type Work @default.
• W4200001593 citedByCount "0" @default.
• W4200001593 crossrefType "journal-article" @default.
• W4200001593 hasAuthorship W4200001593A5008929561 @default.
• W4200001593 hasAuthorship W4200001593A5015485949 @default.
• W4200001593 hasAuthorship W4200001593A5017852065 @default.
• W4200001593 hasAuthorship W4200001593A5026664731 @default.
• W4200001593 hasAuthorship W4200001593A5040670236 @default.
• W4200001593 hasAuthorship W4200001593A5041183761 @default.
• W4200001593 hasAuthorship W4200001593A5046895922 @default.
• W4200001593 hasAuthorship W4200001593A5050186673 @default.
• W4200001593 hasAuthorship W4200001593A5052029724 @default.
• W4200001593 hasAuthorship W4200001593A5053600656 @default.
• W4200001593 hasAuthorship W4200001593A5057537741 @default.
• W4200001593 hasAuthorship W4200001593A5058017922 @default.
• W4200001593 hasAuthorship W4200001593A5065877091 @default.
• W4200001593 hasAuthorship W4200001593A5074893397 @default.
• W4200001593 hasAuthorship W4200001593A5075978935 @default.
• W4200001593 hasAuthorship W4200001593A5077183317 @default.
• W4200001593 hasAuthorship W4200001593A5077266079 @default.
• W4200001593 hasAuthorship W4200001593A5079489250 @default.
• W4200001593 hasAuthorship W4200001593A5081122395 @default.
• W4200001593 hasAuthorship W4200001593A5083052414 @default.
• W4200001593 hasAuthorship W4200001593A5089637129 @default.
• W4200001593 hasBestOaLocation W42000015931 @default.
• W4200001593 hasConcept C126322002 @default.
• W4200001593 hasConcept C187212893 @default.
• W4200001593 hasConcept C2776780178 @default.
• W4200001593 hasConcept C2777910003 @default.
• W4200001593 hasConcept C2778198053 @default.
• W4200001593 hasConcept C534529494 @default.
• W4200001593 hasConcept C71924100 @default.
• W4200001593 hasConceptScore W4200001593C126322002 @default.
• W4200001593 hasConceptScore W4200001593C187212893 @default.
• W4200001593 hasConceptScore W4200001593C2776780178 @default.
• W4200001593 hasConceptScore W4200001593C2777910003 @default.
• W4200001593 hasConceptScore W4200001593C2778198053 @default.
• W4200001593 hasConceptScore W4200001593C534529494 @default.
• W4200001593 hasConceptScore W4200001593C71924100 @default.
• W4200001593 hasIssue "Supplement_1" @default.
• W4200001593 hasLocation W42000015931 @default.
• W4200001593 hasLocation W42000015932 @default.
• W4200001593 hasOpenAccess W4200001593 @default.
• W4200001593 hasPrimaryLocation W42000015931 @default.
• W4200001593 hasRelatedWork W1987215768 @default.
• W4200001593 hasRelatedWork W1995188757 @default.
• W4200001593 hasRelatedWork W2016679923 @default.
• W4200001593 hasRelatedWork W2057721052 @default.
• W4200001593 hasRelatedWork W2116001782 @default.
• W4200001593 hasRelatedWork W2314711404 @default.
• W4200001593 hasRelatedWork W2399217294 @default.
• W4200001593 hasRelatedWork W2423950151 @default.
• W4200001593 hasRelatedWork W2763646354 @default.
• W4200001593 hasRelatedWork W4229900919 @default.
• W4200001593 hasVolume "8" @default.
• W4200001593 isParatext "false" @default.
• W4200001593 isRetracted "false" @default.
• W4200001593 workType "article" @default.